{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:31:53Z","timestamp":1770744713191,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jdcr.2025.09.045","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T08:08:32Z","timestamp":1761379712000},"page":"216-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From plaques to pigment: Eruptive lentiginosis in resolving psoriatic plaques after biologic therapy"],"prefix":"10.1016","volume":"67","author":[{"given":"Sarah","family":"Choe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneri Bhargav","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Phong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Yale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Golbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Zachary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5335-0376","authenticated-orcid":false,"given":"Michelle S.","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2025.09.045_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2230.1994.tb02686.x","article-title":"Multiple lentigines confined to psoriatic plaques","volume":"19","author":"Burrows","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.09.045_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.33470\/2379-9536.1390","article-title":"Eruptive lentigines confined to resolving psoriatic plaques following treatment with Guselkumab","volume":"9","author":"Kilgore","year":"2023","journal-title":"Marshall J Med"},{"issue":"9","key":"10.1016\/j.jdcr.2025.09.045_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jdcr.2018.07.021","article-title":"Eruptive lentiginosis in resolving psoriatic plaques","volume":"4","author":"Micieli","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"10","key":"10.1016\/j.jdcr.2025.09.045_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13483","article-title":"Eruptive lentiginosis in resolving plaque psoriasis during treatment with risankizumab","volume":"29","author":"Palmisano","year":"2023","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.jdcr.2025.09.045_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10067-022-06276-y","article-title":"Eruptive lentigines confined to psoriatic plaques following biologic therapy","volume":"41","author":"Khanna","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.jdcr.2025.09.045_bib6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.abd.2022.04.015","article-title":"Recurrence of psoriasis on the resolution sites left with lentiginous pigmented patches after TNF inhibitor therapy","volume":"98","author":"Yamamoto","year":"2023","journal-title":"Bras Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.09.045_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4274\/jtad.galenos.2023.35229","article-title":"Multiple lentigines in resolving psoriatic plaques after treatment with secukinumab in two cases","volume":"17","author":"Uzun\u00e7akmak","year":"2023","journal-title":"J Turk Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2025.09.045_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15468","article-title":"Persistent eruptive lentiginosis in a psoriatic patient after 4-year effective treatment with ustekinumab","volume":"35","author":"Parietti","year":"2022","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jdcr.2025.09.045_bib9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5021\/ad.2021.33.3.300","article-title":"The first case of ustekinumab-associated hair repigmentation and a proposed mechanism of action","volume":"33","author":"Park","year":"2021","journal-title":"Ann Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.09.045_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000113947","article-title":"Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab","volume":"216","author":"Santos-Juanes","year":"2008","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jdcr.2025.09.045_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.abd.2020.05.011","article-title":"Eruptive lentiginosis confined to areas of regressing psoriatic plaques after adalimumab treatment","volume":"96","author":"Garcia-Souto","year":"2021","journal-title":"Bras Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.09.045_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/jid.2014.297","article-title":"Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents","volume":"135","author":"Di Cesare","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.09.045_bib13","first-page":"11","article-title":"Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept","volume":"14","author":"Costa","year":"2008","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.jdcr.2025.09.045_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1684\/ejd.2015.2572","article-title":"Multiple lentigines in psoriasis patients treated with etanercept","volume":"25","author":"Almaz\u00e1n-Fern\u00e1ndez","year":"2015","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.09.045_bib15","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/pde.12543","article-title":"Lentigines in resolving psoriatic plaques: rarely reported sequelae in pediatric cases","volume":"32","author":"LaRosa","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.09.045_bib16","article-title":"Appearance of lentigines in psoriasis patient treated with guselkumab","volume":"25","author":"Lee","year":"2019","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.jdcr.2025.09.045_bib17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/15569527.2014.959664","article-title":"Multiple lentigines confined to psoriatic plaques induced by biologic agents in psoriasis therapy: a case and review of the literature","volume":"34","author":"Dogan","year":"2015","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.09.045_bib18","first-page":"7079","article-title":"Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature","volume":"9","author":"Mar\u00eda","year":"2017","journal-title":"Dermatol Rep"},{"issue":"4","key":"10.1016\/j.jdcr.2025.09.045_bib19","article-title":"Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy","volume":"20","author":"Guti\u00e9rrez-Gonz\u00e1lez","year":"2014","journal-title":"Dermatol Online J"},{"issue":"10281","key":"10.1016\/j.jdcr.2025.09.045_bib23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jdcr.2025.09.045_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880201","article-title":"Epidemiology of psoriasis and comorbid diseases: a narrative review","volume":"13","author":"Bu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jdcr.2025.09.045_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front Pharmacol"},{"issue":"19","key":"10.1016\/j.jdcr.2025.09.045_bib26","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.3390\/ijms21197041","article-title":"The risk of systemic diseases in those with psoriasis and psoriatic arthritis: from mechanisms to clinic","volume":"21","author":"Woo","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"39","key":"10.1016\/j.jdcr.2025.09.045_bib27","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.2174\/1381612820666140417105323","article-title":"Psoriasis and vascular risk\u202f: an update","volume":"20","author":"Katsiki","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"12","key":"10.1016\/j.jdcr.2025.09.045_bib20","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/jid.2013.237","article-title":"IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis","volume":"133","author":"Wang","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2025.09.045_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/247553031016a00403","article-title":"Which psoriasis patients develop psoriatic arthritis?","volume":"16","author":"Busse","year":"2010","journal-title":"Psoriasis Forum"},{"issue":"5","key":"10.1016\/j.jdcr.2025.09.045_bib22","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/rheumatology\/keab622","article-title":"Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study","volume":"61","author":"Ogdie","year":"2022","journal-title":"Rheumatology (Oxford)"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262500548X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262500548X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:31:22Z","timestamp":1768552282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262500548X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"alternative-id":["S235251262500548X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.09.045","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From plaques to pigment: Eruptive lentiginosis in resolving psoriatic plaques after biologic therapy","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}